More recent studies have reported a decrease in the CD56brightCD16- NK-cell subset and increased CD4CD25FoxP3 regulatory T-cells [12], and CD26 expressed on T-cells and NK-cells (marked with CD2) has been put forward as a promising biomarker in CFS [13]. Here, DPP4 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.